In glioblastoma cells, the knockdown of Bcl2l2-Pabpn1 by targeting its fusion junction resulted in reduced expression, leading to the suppression of cell proliferation, migration, and invasion in vitro (12). This evidence concerns the gene PABPN1 and glioblastoma.